Merck & Co Inc (MRK)

MRK on New York Consolidated

57.63USD
24 Oct 2014
Price Change (% chg)

$1.00 (+1.77%)
Prev Close
$56.63
Open
$56.80
Day's High
$57.47
Day's Low
$56.63
Volume
7,364,112
Avg. Vol
9,629,504
52-wk High
$61.33
52-wk Low
$44.62

MRK

Chart for MRK

About

Merck & Co., Inc. (Merck), is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company consists of four operating segments, which are the Pharmaceut... (more)

Overall

Beta: 0.42
Market Cap (Mil.): $166,183.70
Shares Outstanding (Mil.): 2,884.63
Dividend: 0.44
Yield (%): 3.06

Financials

  MRK Industry Sector
P/E (TTM): 30.37 33.21 34.06
EPS (TTM): 1.90 -- --
ROI: 6.92 18.18 17.45
ROE: 11.71 18.85 18.26
Search Stocks

Ex-Bank of New York Mellon employee pleads guilty to insider trading

NEW YORK - A former Bank of New York Mellon Corp employee on Friday pleaded guilty to insider trading based on tips from a former Merck & Co Inc employee about potential pharmaceutical mergers.

24 Oct 2014

UPDATE 1-Ex-Bank of New York Mellon employee pleads guilty to insider trading

NEW YORK, Oct 24 - A former Bank of New York Mellon Corp employee on Friday pleaded guilty to insider trading based on tips from a former Merck & Co Inc employee about potential pharmaceutical mergers.

24 Oct 2014

Ex-Bank of New York Mellon trader pleads guilty to insider trading

NEW YORK, Oct 24 - A former Bank of New York Mellon Corp trader on Friday pleaded guilty to insider trading based on tips from a former Merck & Co Inc employee about potential pharmaceutical mergers.

24 Oct 2014

Roche, Merck extend immunotherapy fight to breast cancer

LONDON - Swiss drugmaker Roche and U.S. group Merck & Co are to present data on their rival immunotherapy drugs in breast cancer in December, extending the novel approach to fighting tumors to another cancer type.

17 Oct 2014

Roche, Merck extend immunotherapy fight to breast cancer

LONDON - Swiss drugmaker Roche and U.S. group Merck & Co are to present data on their rival immunotherapy drugs in breast cancer in December, extending the novel approach to fighting tumours to another cancer type.

17 Oct 2014

UPDATE 1-Roche, Merck extend immunotherapy fight to breast cancer

(Adds Merck also presenting breast cancer data in December)

17 Oct 2014

Merck unit to pay $31 million to settle fraud claims by U.S. states

- A subsidiary of Merck & Co has agreed to pay U.S. states $31 million to settle claims that it overcharged their Medicaid programs for an antidepressant it had sold at a discount to pharmacy companies, attorney generals from three states said on Wednesday.

15 Oct 2014

Merck unit to pay $31 mln to settle fraud claims by U.S. states

Oct 15, - A subsidiary of Merck & Co has agreed to pay U.S. states $31 million to settle claims that it overcharged their Medicaid programs for an antidepressant it had sold at a discount to pharmacy companies, attorney generals from three states said on Wednesday.

15 Oct 2014

Geographic split likely for GSK mature drugs sale: sources

LONDON - GlaxoSmithKline is seeking binding bids by next month for a range of older drugs worth more than $3 billion, which it is likely to sell by geographical region, according to people with direct knowledge of the process.

14 Oct 2014

Geographic split likely for GSK mature drugs sale -sources

LONDON, Oct 14 - GlaxoSmithKline is seeking binding bids by next month for a range of older drugs worth more than $3 billion, which it is likely to sell by geographical region, according to people with direct knowledge of the process.

14 Oct 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Wright Reports
$75.00
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks